BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh V, Yeoh BS, Abokor AA, Golonka RM, Tian Y, Patterson AD, Joe B, Heikenwalder M, Vijay-Kumar M. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota. Gut Microbes 2020;11:1077-91. [PMID: 32223398 DOI: 10.1080/19490976.2020.1743492] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Nakatsu G. Toward a postbiotic era of microbiome science: Opportunities to advance immunotherapies for hepatocellular carcinoma. J Gastroenterol Hepatol 2021. [PMID: 34665475 DOI: 10.1111/jgh.15715] [Reference Citation Analysis]
2 Wu Y, Wu C, Che Y, Zhang T, Dai C, Nguyễn AD, Duan K, Huang Y, Li N, Zhou H, Wan X, Wang Y, Lei H, Hao P, Li C, Wu Y. Effects of Glycyrrhiza Polysaccharides on Chickens' Intestinal Health and Homeostasis. Front Vet Sci 2022;9:891429. [DOI: 10.3389/fvets.2022.891429] [Reference Citation Analysis]
3 Ji G, Si X, Dong S, Xu Y, Li M, Yang B, Tang Z, Fang X, Huang L, Song W, Chen X. Manipulating Liver Bile Acid Signaling by Nanodelivery of Bile Acid Receptor Modulators for Liver Cancer Immunotherapy. Nano Lett 2021;21:6781-91. [PMID: 34382807 DOI: 10.1021/acs.nanolett.1c01360] [Reference Citation Analysis]
4 Lin W, Djukovic A, Mathur D, Xavier JB. Listening in on the conversation between the human gut microbiome and its host. Curr Opin Microbiol 2021;63:150-7. [PMID: 34352595 DOI: 10.1016/j.mib.2021.07.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Payne E, Harrington K, Richard P, Brackin R, Davis R, Couture S, Liff J, Asmus F, Mutina E, Fisher A, Giuvelis D, Sannajust S, Rostama B, King T, Mattei LM, Lee JJ, Friedman ES, Bittinger K, May M, Stevenson GW. Effects of Vancomycin on Persistent Pain-Stimulated and Pain-Depressed Behaviors in Female Fischer Rats With or Without Voluntary Access to Running Wheels. J Pain 2021:S1526-5900(21)00234-0. [PMID: 34029686 DOI: 10.1016/j.jpain.2021.05.003] [Reference Citation Analysis]
6 Golonka RM, Vijay-Kumar M. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome. Adv Cancer Res 2021;149:171-255. [PMID: 33579424 DOI: 10.1016/bs.acr.2020.10.004] [Reference Citation Analysis]
7 Said I, Ahad H, Said A. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World J Gastrointest Oncol 2022; 14(5): 947-958 [DOI: 10.4251/wjgo.v14.i5.947] [Reference Citation Analysis]
8 Hu Y, He J, Zheng P, Mao X, Huang Z, Yan H, Luo Y, Yu J, Luo J, Yu B, Chen D. Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review. Crit Rev Food Sci Nutr 2021;:1-11. [PMID: 34292103 DOI: 10.1080/10408398.2021.1955654] [Reference Citation Analysis]
9 Man S, Liu T, Yao Y, Lu Y, Ma L, Lu F. Friend or foe? The roles of inulin-type fructans. Carbohydrate Polymers 2021;252:117155. [DOI: 10.1016/j.carbpol.2020.117155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
10 Wen Tan SL, Israeli E, Ericksen RE, Chow PK, Han W. The altered lipidome of hepatocellular carcinoma. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.004] [Reference Citation Analysis]
11 Wu L, Feng J, Li J, Yu Q, Ji J, Wu J, Dai W, Guo C. The gut microbiome-bile acid axis in hepatocarcinogenesis. Biomed Pharmacother 2021;133:111036. [PMID: 33378947 DOI: 10.1016/j.biopha.2020.111036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Bartolini I, Risaliti M, Tucci R, Muiesan P, Ringressi MN, Taddei A, Amedei A. Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment. World J Gastrointest Oncol 2021; 13(11): 1616-1631 [PMID: 34853639 DOI: 10.4251/wjgo.v13.i11.1616] [Reference Citation Analysis]
13 Pauly MJ, Rohde JK, John C, Evangelakos I, Koop AC, Pertzborn P, Tödter K, Scheja L, Heeren J, Worthmann A. Inulin Supplementation Disturbs Hepatic Cholesterol and Bile Acid Metabolism Independent from Housing Temperature. Nutrients 2020;12:E3200. [PMID: 33092056 DOI: 10.3390/nu12103200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang C, Yang M, Ericsson AC. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Front Oncol 2020;10:524205. [PMID: 33163393 DOI: 10.3389/fonc.2020.524205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]